Daisuke Iwashima

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Atomic Force Microscopy

Patient Reported Outcomes

Top Venues

Infectious disease reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yuto Yasuda, Satoru Mutsuo, Motoaki Hamada, Kazuo Murai, Yutaka Hirayama, Kiyoshi Uemasu, Soichi Arasawa, Daisuke Iwashima, Ken-Ichi Takahashi
Aluminium Gauze Reduces SARS-CoV-2 Viral Load in Non-Woven Masks Worn by Patients with COVID-19. Infectious disease reports 14 (2) (2022)
Kana Fujimoto, Satoru Mutsuo, Yuto Yasuda, Soichi Arasawa, Noriyuki Tashima, Daisuke Iwashima, Ken-Ichi Takahashi
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants. Infectious disease reports 14 (6) (2022)
Kana Fujimoto, Satoru Mutsuo, Yuto Yasuda, Soichi Arasawa, Noriyuki Tashima, Daisuke Iwashima, Ken-Ichi Takahashi
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants. Infectious disease reports 14 (6) (2022)
Kana Fujimoto, Satoru Mutsuo, Yuto Yasuda, Soichi Arasawa, Noriyuki Tashima, Daisuke Iwashima, Ken-Ichi Takahashi
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants. Infectious disease reports 14 (6) (2022)
Kana Fujimoto, Satoru Mutsuo, Yuto Yasuda, Soichi Arasawa, Noriyuki Tashima, Daisuke Iwashima, Ken-Ichi Takahashi
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants. Infectious disease reports 14 (6) (2022)